| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |